This message was sent to ##Email##
Did you miss the ASHI 44th Annual Meeting in Baltimore? Purchase ASHI Access* now - recordings from the Annual Meeting - for only $75!
*Session recordings will be available to access approximately one month after the meeting ends. Only sessions where the speakers have given permission to share their presentations will be included.
ASHI Access is a comprehensive body of knowledge readily accessible to anyone needing information from the 44th Annual Meeting.
If you have any questions, please contact Victoria Ramsay at firstname.lastname@example.org.
- Convenient and easy to access audio synchronized to PowerPoint
- Broad range of materials consistent with today's latest research
- Includes access to most of the sessions from the 44th Annual Meeting including symposia, Hot Topics, Concurrent Oral Abstracts and Workshops
One of the key conclusions from the first STAR meeting held in 2017 was that a major gap in risk stratification for organ transplantation is (lack of) knowledge, and more importantly, tools to detect potential of immune-memory responses prior to transplantation. Additionally, risk stratification and the immunobiology that leads to generation of de novo donor specific antibody production is poorly understood.
ASHI is proud to announce that it is supporting the 2019 STAR session which will be held just prior to the AST CEoT meeting in Feb 2019. The half day STAR 2019 meeting is designed to present current knowledge and have open discussions that will lead to the second STAR publication, with further recommendations for risk stratification.
The STAR 2019 Meeting will take place on Thursday, February 21st. To register for CEoT 2019 and the STAR 2019 Pre-Meeting, please click here.
HLA Typing, NGS, almost no ambiguity, Affordable, Accurate, Quick turnaround time. Reports are uploaded to compatible laboratory software. HLA antibody identification by SAB or C1q, KIR typing, Cancer gene screening and many more.
Questions regarding our testing or to discuss your needs, please contact us at 972-566-8478, 972-566-6278 or 972-566-5761 or visit our website at texasmedicalspecialty.com.
The Accreditation Review Board (ARB) is pleased to announce the new logo design for our accredited laboratories. This will promote pride in the accreditation that our laboratories work extremely hard to obtain.
Laboratory personnel are encouraged to use the logo in their email signatures, if permitted by their institution. The ARB will also use the logo in the following ways:
Melissa Weeks emailed the logo out to all ASHI accredited laboratory contacts the week of October 22nd. If you have not received the electronic logo file and would like one emailed, please contact Melissa directly at email@example.com.
- Use it to create wall & window stickers, for laboratories to display onsite
- Feature it on official accreditation certificates, starting in late 2019
- Any other creative usage is encouraged!
International Summer School
Sunday, July 14 - Wednesday, July 17, 2019
Marriott Springhill Suites Old Montreal
The International Summer School, sponsored by ASHI, EFI, APHIA, and ARSHI, provides a focused course on all aspects of theoretical and applied immunogenetics and histocompatibility. The meeting is limited to a small group of participants and is geared toward graduate students, post-doctoral fellows, laboratory directors in training and experienced technologists in the field of histocompatibility and/or immunogenetics with an interest in research or advanced learning opportunities. Stay tuned for more information to come.
Name & Credentials: John Crawford, BS, CHS
Title: Retired Lab Supervisor
Place of employment: Mayo Clinic in Arizona
Graduated from: North Carolina Central University
How long have you been an ASHI member? 30+ years
When did you attend your first ASHI Meeting? My first ASHI Meeting was in Boston 1978. ASHI was then known as the American Association for Histocompatibility Testing (AACHT). It was great to be able to meet the early pioneers in the field.
Click here to read more.
To be our next ASHI Member Spotlight, click here now! You can also nominate a co-worker or fellow colleague by contacting Mandi Cruz at Mcruz@ashi-hla.org.
The 18th IHIWS is being organized by Dr. Sebastiaan Heidt and Dr. Eric Spierings in Amsterdam, Netherlands. The meeting will be held on May 6-10, 2021 at the Westergasfabriek. The 18th IHIWS will be supported by the Dutch HLA Working Party (HLA-WN), consisting of many internationally respected professionals in the Immunogenetics and Histocompatibility field. The organizing committee has a strong commitment and aims to be very active in making sure all goals of the workshop are reached.
Click here to view the preliminary program.
The 35th EFI Conference
The 18th IHIWS will be followed by the 2021 annual EFI meeting in Amsterdam, Netherlands. This joint structure will allow for the participants of the 18th IHIWS to join the 2021 annual EFI meeting.
Since the end of the 17th IHIWS meeting in Asilomar, USA, there has been a lot of activity behind the scenes. First, components and project leaders have been identified and added to our project database. The project database will be open for new projects until the 30th of November 2018, after which no more new projects can be included. We have also initiated the development of a cloud-based IT infrastructure for the IHIWS data to be stored and analyzed.
Together with ASHI, EFI and APHIA we have appointed liaisons to act as intermediates between the HLA societies and the workshop to keep each other informed. Additionally, we have installed an advisory committee of experts in our field and appointed local hubs to allow for maximum participation all over the world. They serve as spokespersons of the IHIWS to get the labs in their region excited to join the projects and help them in the process of getting and staying involved.
For the concluding meeting in 2021, we have secured a great location in Amsterdam called 'de Westergasfabriek.' This is an old gas factory with several small buildings in which the meeting will be held. The inspiring environment of this remarkably peaceful location in the center of Amsterdam will surely provide the basis for a productive meeting.
Follow the News
To subscribe to the 18th IHIWS newsletter, click here.
The 2018 AC-2 samples recently shipped on Tuesday, October 23rd. AC-2 results are due by 11:59PM Pacific time on Friday, November 30, 2018.
The 2018 HT-2 review process has begun.
The 2018 EMO-2 survey will be shipped on Tuesday, November 6th. Results for EMO-2 are due by 11:59PM Pacific time on Friday, December 7th.
ASHI's 2019 Regional Education Workshop
dates and locations are now available!
April 11-13, 2019
Crowne Plaza Portland Downtown Convention Center
June 27-29, 2019
The DeSoto Hotel
Stay tuned for more information.
The IPTA 2019 Congress will be held on May 4-7 in Vancouver, BC, Canada. ASHI is proud to announce their partnership with IPTA for the Plenary Session: Lab Meets Clinical – Antibodies and Sensitization, featuring speaker and former ASHI President Dr. Anat Tambur.
Click here for event details or visit www.ipta2019.org.
Click here to submit your abstracts by November 5, 2018. All abstracts will be published electronically in the official journal of the International Pediatric Transplant Association – Pediatric Transplantation.
Check out the professional photos from the 2018 ASHI Annual Meeting in Baltimore. Click here to start viewing them. Feel free to save them, share them and post them to your social media using the hashtag #ASHIAnnual2018.
Mark your calendar now for future ASHI Annual Meetings!
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
The gold standard for typing at the allele level of the highly polymorphic Human Leucocyte Antigen (HLA) gene system is sequence based typing. Since sequencing strategies have mainly focused on identification of the peptide binding groove, full-length sequence information is lacking for >90% of the HLA alleles.
The human leukocyte antigen (HLA) genes are highly variable and are known to play an important role in disease outcomes, including infectious diseases. Prior knowledge of HLA polymorphisms in a population usually forms the basis for an effective case-control study design.
Histocompatibility labs must convert molecular HLA typing data to antigen equivalencies for entry into the United Network for Organ Sharing (UNOS) UNet system. While an Organ Procurement and Transplantation Network (OPTN) policy document provides general guidelines for conversion, the process is complex because no antigen mapping table is available.
Intravenous Ig (IVIg), plasma exchange, and immunoadsorption are frequently used in the management of severe autoimmune diseases mediated by pathogenic IgG autoantibodies. These approaches modulating IgG levels can, however, be associated with some severe adverse reactions and a substantial burden to patients. Targeting the neonatal Fc receptor (FcRn) presents an innovative and potentially more effective, safer, and more convenient alternative for clearing pathogenic IgGs.
*As recommended by the Science & Technology Initiatives Committee
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8